Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced Libido
This study has been completed.
Study NCT00566384   Information provided by Bayer
First Received: November 29, 2007   Last Updated: April 27, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Decreased Libido
Interventions listed in this trial
Dehydroepiandrosterone, BAY86-5314
Placebo
Additional drug interventions recognized in this trial
Contraceptive Agents
Contraceptives, Oral
Dehydroepiandrosterone
More general drug interventions related to this trial
Adjuvants, Immunologic
Contraceptive Agents, Female
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services